JK
Jayesh Kevalchand Sancheti
About Jayesh Kevalchand Sancheti
Jayesh Kevalchand Sancheti has 15 years in corporate governance. Holds Director role. Currently with 3 companies, including Neomed Diagnostics Private Limited and Anand Chemiceutics Private Limited. Formerly with 1 company, such as Biogenics Labs Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Neomed Diagnostics Private Limited
U24230PN2022PTC213094
|
Director | 15 Jul 2022 | 2022 | Active |
|
Anand Chemiceutics Private Limited
U51909PN2022PTC214898
|
Director | 20 Sep 2022 | 2022 | Active |
|
Genovations Diagnostics Private Limited
U20299GJ2025PTC159741
|
Director | 02 Mar 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
|
Biogenics Labs Private Limited
U74900PN2011PTC139509
|
Director | 11 May 2011 | 2011 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jayesh Kevalchand Sancheti
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jayesh Kevalchand Sancheti
Jayesh Kevalchand Sancheti has 15 years in corporate governance. Holds Director role. Currently with 3 companies, including Neomed Diagnostics Private Limited and Anand Chemiceutics Private Limited. Formerly with 1 company, such as Biogenics Labs Private Limited. Engaged in General Business. Contributes to corporate operations.
Jayesh Kevalchand Sancheti is associated with 3 companies as Director.
Jayesh Kevalchand Sancheti has expertise in General Business.
Jayesh Kevalchand Sancheti has 15 years in corporate governance.